-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MtLgyv/oV9vTdos2WDWZiPbKDReXSyfv88eeop88MYcj+OtFy0ra9ug3SujOMuaC 5DQkFkVz4MsRLxKP9s4DDw== 0001209191-05-030547.txt : 20050611 0001209191-05-030547.hdr.sgml : 20050611 20050607161158 ACCESSION NUMBER: 0001209191-05-030547 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050603 FILED AS OF DATE: 20050607 DATE AS OF CHANGE: 20050607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rubinstein Linda M CENTRAL INDEX KEY: 0001321937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 05883053 BUSINESS ADDRESS: BUSINESS PHONE: (510) 670-9300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 4 1 bpa09828_bparu.xml MAIN DOCUMENT DESCRIPTION X0202 4 2005-06-03 0000913275 Solexa, Inc. SLXA 0001321937 Rubinstein Linda M C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. HAYWARD CA 94545 0 1 0 0 VP & Chief Financial Officer Employee Stock Option 6.11 2005-06-03 4 A 0 141000 6.11 A 2015-06-03 Common Stock 141000 141000 D This option will vest and become exercisable in forty-eight (48) equal monthly installments over four (4) years, with vesting to commence as of March 22, 2005. Upon the consummatin of an Asset Sale, Merger, Consolidation or Reverse Merger, each as defined in the Company's 1992 Stock Option Plan, the vesting and exercisability of the option shall be accelerated two (2) years. /s/ Linda Rubinstein 2005-06-05 POA: Kathy A. San Roman 2005-06-05 -----END PRIVACY-ENHANCED MESSAGE-----